© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Saxagliptin monohydrate appears as a solid form of a popular pharmaceutical intermediate, recognized by its clear white to off-white crystalline powder or fine flakes. With a molecular formula of C18H25N3O2·H2O and a molar mass near 333.42 g/mol, saxagliptin monohydrate stands apart for its water content, which can affect processing and handling in manufacturing environments. The substance forms well-defined crystals, easily observed under simple magnification, and can present as loosely adhering powder, fine flakes, or small, shiny pearls, depending on the drying method and batch preparation conditions. HS Code 2933990090 typically identifies it for international trade and regulatory tracking purposes.
Known for its stable crystalline structure, saxagliptin monohydrate holds a density hovering around 1.4 g/cm³. This isn't a dense material by industrial standards, so it pours fairly smoothly and doesn't compact easily, making transfer and weighing simple during raw material handling. Many technicians working in solid formulation labs recognize its slick, near-luminescent crystal faces, which distinguish it from basic amorphous powders. Handling the bulk material, there’s a noticeable lack of clumping, which generally signals a high-quality, well-dried material. The substance does not melt at room temperature, instead requiring a controlled heating process to liquefy as it decomposes beyond 120°C. This threshold gives processors a clear window for safe manipulation and stress testing within R&D settings.
Saxagliptin monohydrate’s structure is a blend of fused bicyclic systems and distinctive nitrogen positions, offering unique interactions with water molecules. The water in its monohydrate form stabilizes the crystal lattice, which can change under variable humidity. Any lab with experience in storing this compound knows the water content impacts overall stability; loss of water shifts the substance from a monohydrate to an anhydrous phase, changing handling characteristics. Because of this, packaging often features moisture-protective barriers. The hygroscopic nature makes it necessary to track storage conditions, ensuring that the product maintains its intended properties. Technicians have found tight, double-sealed drums or high-barrier foil packs reduce risk for property changes in volatile climates.
Every batch of saxagliptin monohydrate undergoes strict analysis for chemical purity, moisture content, and particle size. Typical specifications call for a purity above 98%, moisture below 5%, and standardized particle size distribution. A precise formula, C18H25N3O2·H2O, matches spectroscopic analysis and assures downstream consistency. Quality relies on thorough documentation, and many manufacturers provide full certificates of analysis, ensuring that any deviation—be it a denser clump or color change—flags a potential contamination issue or process deviation. Material in bulk must pass uniformity and loss-on-drying tests. Historically, compounds that fail to meet set density or loss-on-drying targets have caused issues during blending or compression, slowing production and causing recalls that ripple through the entire supply chain.
Saxagliptin monohydrate does not present broad acute toxicity hazards in small-scale use but does demand careful handling due to the potential for respiratory and eye irritation. Technicians with years at the bench will recall episodes where improper dust containment led to sneezing, watery eyes, or throat discomfort, underlining the need for personal protective equipment, modern ventilation, and careful transfer protocols. As with many raw chemical materials, the compound requires storage in cool, low-light environments—direct sunlight and high humidity can trigger degradation or clumping. Material Safety Data Sheets recommend gloves, tight-fitting goggles, and dust masks for transfers or open handling. If the fine powder becomes airborne or spills on skin, prompt washing and vacuum extraction minimize exposure risks. A warehouse accident involving spilled saxagliptin monohydrate once halted operations until the cleanup crew finished aspirating and neutralizing the incident, highlighting the need for good risk planning during bulk raw material shipments.
Saxagliptin monohydrate serves as the core active ingredient input for advanced type 2 diabetes therapeutics. Because it reacts with common pharmaceutical excipients and solvents, producers always want to know its specific density, water content, and particle morphology. Incorrect density values can shift dosing calibration, and excess water can weaken tableted drugs, causing them to break or wear during packaging. Colleagues in pharmaceutical plants have stressed how the raw crystal form, along with accurate density and moisture values, makes direct compression and blending more predictable. Every supplier’s quality control team faces the same questions about purity, density, particle size, and storage—real-world lessons learned after years of returned or rejected drug lots due to overlooked physical properties or changing shipment moisture levels. Monitoring these parameters, communicating them clearly, and double-checking every logistics chain stage stands out as the most practical way forward.
To reduce chemical degradation or hazardous exposure, manufacturers put a premium on smart packaging and advanced lab tracking. Materials shipped in vacuum-sealed, tamper-evident containers lose fewer batches to moisture drift. Laboratories leverage rapid spectroscopic tools and chromatography to catch deviations early. Safety remains a constant concern; continuous training for material handlers, well-marked emergency wash stations, and up-to-date SDS documentation save time and prevent injuries, averting disruptions that slow production. Perhaps the most useful change comes from two-way communication across procurement, shipping, and production. Conducting annual supplier audits, using tamper-proof seals, and cross-verifying each lot through independent labs all contribute to fewer safety incidents and tighter specifications. Real lives depend on the reliability of every chemical batch—tight quality control processes, personal vigilance, and transparent sourcing build trust and keep pharma supply chains running safely and smoothly.
